The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials
Abstract
Abstract We conducted a meta-analysis to investigate the effects of the Mediterranean Diet (Med-Diet) on hepatic steatosis and insulin resistance in patients with nonalcoholic fatty liver disease (NAFLD). Six randomized controlled trials were selected for the meta-analysis (sample size: 250 participants). In the meta-analysis, there was no significant difference in body mass index and waist circumference between the Med-Diet and control groups. Med-Diet significantly reduced fatty liver index (FLI) compared with the control diet (standard mean difference [SMD]: –1.06; 95% CI: –1.95 to –0.17; p = 0.02). Med-Diet significantly reduced homeostasis model assessment of insulin resistance (HOMA-IR) compared with the control diet (SMD: –0.34; 95% CI: –0.65 to –0.03; p = 0.03). Similarly, a meta-regression analysis using age showed that Med-Diet significantly reduced FLI and HOMA-IR (95% CI: –0.956 to –0.237, p = 0.001 and 95% CI: –0.713 to –0.003, p = 0.048, respectively). This meta-analysis demonstrated that Med-Diet improved hepatic steatosis and insulin resistance in patients with NAFLD. Thus, Med-Diet is a beneficial pharmaconutritional therapy in patients with NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is limited data on long-term dietary interventions in MASLD since study durations range from 2-24 months. 283 -285”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [285]
In the citing paper
“However, the Mediterranean diet seems to have added value for liver lipid reduction and cardiometabolic health and may be easier to maintain in the long-term. 285,287”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [285]
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,146
Sheka, A. C., Adeyi, O. A., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,421
Borenstein, M., Hedges, L. V., Higgins, J. P. T., Rothstein, H. R., & Den, A. B. V. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.121 · Cited by 1,260
The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
Kastorini, C.-M., Milionis, H. J., Esposito, K., Giugliano, D., Goudevenos, J. A., & Panagiotakos, D. B. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.073 · Cited by 1,087
Dinu, M., Pagliai, G., Casini, A., & Sofi, F. (2018) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.58 · Cited by 1,016
Stefan, N., Häring, H., & Cusi, K. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 874
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–123 of 123
Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), An Underappreciated Threat.
Buzaid, N. O., & Lawgaly, S. A. (2025) · Benghazi University Medical Journal · doi:10.37376/benunivmedj.v1i1.7364
Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), An Underappreciated Threat.
Buzaid, N. O., & Lawgaly, S. A. (2025) · Benghazi University Medical Journal · doi:10.37376/benunivmedj.v2i1.7364
Rebelos, E., & Kounatidis, D. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00273-9
Strużek, K., Kwiatkowska, A., Mączka, E., Tracz, W., Świercz, P., Teper, K., Khiralla-Gawlik, S., Strzelecka, A. A., & Basak, A. E. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3662
Cernea, S., Onișor, D. M., & Roiban, A. L. (2025) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2025-0030
Real-World Lifestyle Interventions are a Practical Model to Improve Liver Stiffness
Kasia, C., & Rinella, M. E. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.103201
Demidova, T. Y., Titova, V. V., Levitskaya, A. N., & Gyozalyan, M. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-456
Giannitrapani, L., Ferraro, M., Seidita, A., Licata, A., & Soresi, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i12.110076
De Novo and Recurrent Metabolic Dysfunction Associated Steatotic Liver Disease
Parsa, L., & Satapathy, S. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-2624-6_37
Tailleux, A., & Kamel, S. (2026) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(26)76568-0
Kouti, T., Christodoulou, P., Christodoulides, S., Protopapa, F., Michaeloudes, C., & Farazi, P. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1767917
Andrade, L. J. D. O., de Oliveira, G. C. M., Paraná, R., Bittencourt, A. M. V., Salles, O. J. D. M., & de Oliveira, L. M. (2026) · Research Square · doi:10.21203/rs.3.rs-8818597/v1
Romero-Gómez, M., Escalada, J., Noguerol, M., Pérez, A., Carretero, J., Crespo, J., Mascort, J. J., Aguilar, I., Tinahones, F., Cañones, P., et al. (2026) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2026.502639
Fouad, Y. M., Pan, Z., Mostafa, A. M., & Eslam, M. (2026) · World Journal of Meta-Analysis · doi:10.13105/wjma.v14.i1.113789
Zhang, Z.-R., She, L., Cao, Y., & Chen, Y.-W. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i4.116074
Nutrition Therapy for Metabolic Liver Disease and Diabetes
Guinane, A., & Pezzuto, D. (2026) · American Diabetes Association eBooks · doi:10.2337/9781580408493-ch15
Dietvorst, C. A. W., Konings, L. A. M., Saidi, A. N., Noordermeer, T., van Wenum, M., Peeters, R. P., Berk, K. A., & Cabezas, M. C. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113058
Tatoli, R., Donghia, R., Carella, N., Cerabino, N., Chito, M. D., Zappimbulso, M., Pesole, P. L., Stabile, D., Ferro, A., Pascale, G., et al. (2026) · Nutrients · doi:10.3390/nu18152476
Zhao, R., Zheng, J.-L., Wang, Y., Lu, B., Zhang, Y., & Deng, B.-C. (2026) · World Journal of Hepatology · doi:10.4254/wjh.124748
Neue Therapieansätze bei MASH: Mechanismen und klinisches Potenzial
Barton, A., & Schattenberg, J. M. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2894-7716
The Mediterranean pyramid: 30 years later, still relevant
Visioli, F., Martínez‐Urbistondo, D., & Martínez‐González, M. Á. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04114-4
Hong, D., Xi, B., Lv, Z., Li, N., He, X., Zhu, X., Zhang, J., Wang, C., Cai, Z., Wu, H., et al. (2026) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003290
Navigating MASLD heterogeneity: from metabolic risk to precision stratification
Yan, C., Zhang, G., Liang, L., & He, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1966460
Metadata
- Authors
- Kawaguchi, T., Charlton, M., Kawaguchi, A., Yamamura, S., Nakano, D., Tsutsumi, T., Zafer, M., & Torimura, T.
- Affiliations
- Kurume University (JP)
- University of Chicago (US)
- Saga University (JP)
- Corresponding author
- Charlton, Michael
- ORCID
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2021-06-19
- Volume
- 41
- Issue
- 03
- Pages
- 225-234
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W3171675307
- Cited by
- 122
- References
- 48
- Citations by year
- 2026: 29 · 2025: 36 · 2024: 21 · 2023: 19 · 2022: 14 · 2021: 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Agency for Medical Research and Development (JP20fk0210040)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- Mediterranean diet, non-alcoholic fatty liver disease, hepatic steatosis, insulin resistance, fatty liver index, HOMA-IR, dietary intervention
- MeSH terms
- Humans, Insulin Resistance, Regression Analysis, Randomized Controlled Trials as Topic, Diet, Mediterranean, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
